
Through a voluntary field safety notification, Insulet Corporation is notifying consumers and health care professionals about a slight increase in reports in which the OmniPod's needle mechanism to deliver insulin fails to deploy or is delayed.

Through a voluntary field safety notification, Insulet Corporation is notifying consumers and health care professionals about a slight increase in reports in which the OmniPod's needle mechanism to deliver insulin fails to deploy or is delayed.

Warnings about the risk of ketoacidosis and serious urinary tract infections have been added to the labels of SGLT2 inhibitors.

Potentially game changing drug may alter diabetes disease course.

Warnings about the risk of ketoacidosis and serious urinary tract infections have been added to the labels of SGLT2 inhibitors.

Is metformin the magic cure to slow the aging process?

People with sleep schedule disruptions more likely to be resistant to insulin.

Once-daily tablets treat type 2 diabetes in adults as an adjunctive treatment to diet and exercise to improve glycemic control.

Shifts in sleep schedules may increase an individual's risk for diabetes.

Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).

What you eat and drink on Thanksgiving can significantly affect some medications.

Pharmacists help set goals for patients with type 2 diabetes.

Women with type 2 diabetes have greater difficulty with exercise than those without the condition.

Approximately 29.1 million individuals in the United States have diabetes, and an estimated 8.1 million cases are undiagnosed.

Intervention doubles chance of having well-controlled blood sugar post-surgery.

Patients with diabetes fare better after surgery when pharmacists manage their high blood sugar.

Micro RNA based blood test may be used with imaging features to accurately predict disease severity.

Finding treatments that deliver better glycemic control is critical.

Individuals who develop type 2 diabetes tend to take more antibiotics in the years leading up to their diagnosis than those without the condition.

Metabolic or bariatric surgery may be more effective than standard medical treatments at controlling type 2 diabetes in patients who are obese.

Daily injection of the diabetes drug liraglutide can lead to greater weight loss when used in addition to diet and exercise.

Drug similarities increase the chance of a medication error.

Drug helps improve glycemic control of type 2 diabetes not adequately controlled on a regimen of empagliflozin or metformin alone.

If all individuals with diabetic retinopathy were treated in a timely manner, the incidence of blindness from diabetes could be decreased by 90%.

If all individuals with diabetic retinopathy were treated in a timely manner, the incidence of blindness from diabetes could be decreased by 90%.

Synjardy, a type 2 diabetes treatment, is now available by prescription in US pharmacies.